Tag: epigenetics market overview

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Epigenetics Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The epigenetics market has experienced substantial growth in recent years. Its value is expected to rise from $12.74 billion in 2025 to $15.62 billion in 2026, at a compound annual growth rate (CAGR) of 22.6%. Historically, this expansion can be linked to heightened cancer research activities, the broadening of academic genomics research, the accessibility of advanced sequencing instruments, an increasing emphasis on molecular diagnostics, and greater funding allocated to life sciences research.

The epigenetics market is anticipated to experience significant expansion in the coming years. It is projected to reach $35.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 22.3%. This projected growth during the forecast period is fueled by factors such as greater investments in precision medicine, the growing embrace of epigenetic therapeutics, the broadening scope of personalized oncology treatments, the expanding application of AI-driven genomic analysis, and heightened collaboration between pharmaceutical companies and research institutions. Key trends for the same period encompass the heightened utilization of epigenetic biomarkers in oncology, the increasing uptake of high-throughput epigenetic analysis instruments, a rising demand for DNA methylation assays, the broadening of epigenetics-driven drug discovery efforts, and improved integration of bioinformatics platforms.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=29548743&type=smp&name=Epigenetics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Epigenetics Market Growth Catalysts And Demand Drivers

The epigenetics market is anticipated to expand due to a growing emphasis on precision medicine in the future. This medical strategy involves tailoring treatments to specific patient requirements by taking into account their unique genetic makeup, environmental factors, and lifestyle choices. Within epigenetics, precision medicine leverages individual epigenetic profiles and genetic data to develop customized healthcare plans, leading to more effective disease management and patient treatment. As an illustration, Novotech, an Australia-based biotechnology company, reported in March 2024 that in 2023, 43% of the 217 FDA-approved oncology treatments were precision oncology treatments, and 78 of these included DNA or NGS-detectable biomarkers. Consequently, the growing focus on precision medicine is stimulating the expansion of the epigenetics market.

Epigenetics Market Segment Analysis: What Are The Core Market Categories?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Epigenetics Market Trends Shaping Long-Term Demand

Major companies operating in the epigenetics market are intensifying their efforts to implement artificial intelligence (AI)-driven analytics, aiming to gain a competitive edge. AI-driven analytics involves employing artificial intelligence (AI) technologies to automatically process and interpret significant amounts of data. As an illustration, FOXO Technologies, a US-based firm, unveiled its Bioinformatics Services in July 2023, designed to transform epigenetic data analysis. FOXO’s Bioinformatics Services provide a adaptable platform of sophisticated data solutions, customized to address the particular requirements of clients working in academia, healthcare, and pharmaceutical research. Utilizing a cutting-edge suite of bioinformatic tools, FOXO seeks to empower its clients to boost the speed and accuracy with which they process, analyze, and interpret data sets, thereby accelerating discoveries and deepening their understanding of complex diseases.

Epigenetics Market Industry Leaders And Competitive Landscape

Major companies operating in the epigenetics market are Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

View The Full Epigenetics Market Report:

https://thebusinessresearchcompany.com/report/epigenetics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Epigenetics Market Regional Analysis And Leading Geography

North America was the largest region in the epigenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The epigenetics market has witnessed remarkable growth recently and is set to continue this upward trajectory in the coming years. Driven by advancements in research and technology, this sector is becoming increasingly vital in precision medicine and cancer treatment. Let’s explore the market’s current size, growth drivers, emerging trends, major players, and regional dynamics shaping its future.

Rapid Expansion and Size Forecast of the Epigenetics Market

The epigenetics market has experienced significant growth, expanding from $12.74 billion in 2025 to an estimated $15.62 billion in 2026, reflecting a compound annual growth rate (CAGR) of 22.6%. This surge during the past period results from heightened cancer research activities, the broadening scope of academic genomics studies, improved availability of advanced sequencing instruments, and an increased focus on molecular diagnostics backed by rising funding in life sciences research. Looking ahead, the market is projected to soar to $35.01 billion by 2030 at a CAGR of 22.3%, fueled by investments in precision medicine, growing acceptance of epigenetic therapies, expansion of personalized oncology, AI-powered genomic analysis, and stronger partnerships between pharmaceutical companies and research institutions. Important trends expected to influence this growth include wider use of epigenetic biomarkers in cancer, adoption of high-throughput analysis tools, increasing demand for DNA methylation assays, advances in drug discovery based on epigenetics, and better integration of bioinformatics platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Precision Medicine as a Major Catalyst in Epigenetics Market Growth

An intensified emphasis on precision medicine is one of the primary factors driving the epigenetics market forward. Precision medicine tailors treatments based on an individual’s genetic makeup, environmental factors, and lifestyle, enabling more personalized and effective healthcare approaches. Within epigenetics, this means utilizing unique epigenetic profiles alongside genetic data to design targeted treatment strategies for patients. For example, in March 2024, Novotech, an Australian biotechnology firm, reported that in 2023, 43% of the 217 oncology therapies approved by the FDA were precision oncology treatments, with 78 of these involving DNA or next-generation sequencing (NGS) biomarkers. Such data highlights how the focus on precision medicine is instrumental in accelerating epigenetics market expansion.

Segmentation Highlights Uncovering Key Opportunities in the Epigenetics Market

This report breaks down the epigenetics market by several key segments:

1) Product categories including reagents, enzymes, instruments, and kits;

2) Technology types such as DNA methylation, histone methylation, histone acetylation, large noncoding RNA, microRNA modification, and chromatin structures;

3) Applications across oncology, metabolic diseases, developmental biology, immunology, cardiovascular disorders, and others;

4) End users comprising academic and research institutes, pharmaceutical and biotechnology firms, contract research organizations, and additional user groups.

Further subcategories dive deeper, for instance, reagents include DNA methylation reagents, histone modification reagents, RNA modification reagents, and enzymes; enzymes are divided into DNA methyltransferases, histone acetyltransferases, and histone deacetylases; instruments cover sequencers, PCR machines, microarray platforms, and mass spectrometers; kits include DNA methylation kits, chromatin immunoprecipitation (ChIP) kits, RNA-Seq kits, and bisulfite conversion kits.

Access The Complete Epigenetics Market Report:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

How AI and Bioinformatics Are Influencing Epigenetics Market Trends

Leading companies in the epigenetics sector are increasingly leveraging artificial intelligence (AI) to gain a competitive advantage by enhancing data analytics capabilities. AI-driven analytics involve using advanced AI technologies to automatically process and interpret vast quantities of data, accelerating research and discovery. For example, in July 2023, FOXO Technologies, a US-based company, launched Bioinformatics Services designed to transform epigenetic data analysis. Their platform offers a range of customizable data solutions tailored to the needs of academic institutions, healthcare providers, and pharmaceutical researchers. By employing innovative bioinformatic tools, FOXO aims to improve the speed and accuracy of data processing, helping clients advance their understanding of complex diseases more efficiently.

Top Companies Influencing the Direction of the Epigenetics Market

Key players dominating the epigenetics industry include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., and Valirx plc. These organizations are at the forefront of innovation, research, and market expansion within this field.

Regional Patterns Revealing Growth Hotspots in the Epigenetics Market

In 2025, North America held the largest share of the epigenetics market, driven by strong research infrastructure and funding. Looking toward the future, the Asia-Pacific region is expected to exhibit the fastest growth during the forecast period, fueled by increasing investments, expanding research activities, and growing healthcare awareness. The market report covers key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a broad perspective on global expansion trends.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Epigenetics Market Through 2030?

The epigenetics market has experienced rapid expansion in recent years. It is projected to grow from $12.74 billion in 2025 to $15.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.6%. This historical growth can be credited to factors such as increasing cancer research activities, the expansion of academic genomics research, the availability of advanced sequencing instruments, a growing emphasis on molecular diagnostics, and rising funding for life sciences research.

The epigenetics market is poised for significant expansion in the coming years. Projections indicate it will reach a value of $35.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.3%. This anticipated growth throughout the forecast period stems from factors such as increased investments in precision medicine, the growing acceptance of epigenetic therapeutics, the broader application of personalized oncology treatments, the expanding utilization of AI-driven genomic analysis, and enhanced collaborations between pharmaceutical companies and research institutions. Key trends anticipated during this period encompass the escalating use of epigenetic biomarkers in oncology, a greater uptake of high-throughput epigenetic analysis tools, the increasing need for DNA methylation assays, the broadening scope of epigenetics-based drug discovery initiatives, and improved integration of bioinformatics platforms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Which Major Factors Are Contributing To The Development Of The Epigenetics Market?

The epigenetics market is anticipated to expand due to a growing emphasis on precision medicine in the future. This medical strategy tailors treatment to individual requirements by examining genetic, environmental, and lifestyle data. Within epigenetics, precision medicine leverages personalized epigenetic profiles and genetic information to develop customized healthcare plans, leading to more effective disease management and patient treatment. For example, Novotech, an Australia-based biotechnology firm, reported in March 2024 that in 2023, out of 217 FDA-approved oncology treatments, 43% were precision oncology therapies, with 78 of these featuring DNA or NGS-detectable biomarkers. Consequently, the heightened focus on precision medicine is fueling the expansion of the epigenetics market.

Which Segment-Based Categories Are Covered In The Epigenetics Market?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Which Trends Are Guiding The Development Of The Epigenetics Market?

Leading companies operating within the epigenetics market are increasingly prioritizing the adoption of artificial intelligence (AI)-driven analytics to secure a competitive advantage. AI-driven analytics is defined as the utilization of artificial intelligence (AI) technologies to automatically process and comprehend vast quantities of data. For instance, in July 2023, FOXO Technologies, a US-based firm, introduced Bioinformatics Services, designed to revolutionize epigenetic data analysis. FOXO’s Bioinformatics Services deliver a flexible platform of cutting-edge data solutions, specifically tailored to cater to the unique demands of clients across academia, healthcare, and pharmaceutical research. Utilizing an innovative array of bioinformatic tools, FOXO’s objective is to equip its clients to enhance the speed and accuracy with which they handle, analyze, and interpret data sets, thereby accelerating new discoveries and fostering a greater comprehension of complex diseases.

Who Are The Major Companies Operating In The Epigenetics Market?

Major companies operating in the epigenetics market are Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Access The Complete Epigenetics Market Report:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Region Holds The Largest Share In The Epigenetics Market?

North America was the largest region in the epigenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Epigenetics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2026, By The Business Research Company

Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Epidural Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/epidural-catheter-global-market-report

Anesthesia Circuits And Regional Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-circuits-and-regional-anesthesia-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Epigenetics Market Expected To Scale Between 2026 And 2030?

The epigenetics market has witnessed significant growth in recent years. It is anticipated to increase from $12.74 billion in 2025 to $15.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.6%. This historic expansion is largely due to increasing cancer research activities, the expansion of academic genomics research, the availability of advanced sequencing instruments, a growing focus on molecular diagnostics, and rising funding for life sciences research.

The epigenetics market is poised for significant expansion over the coming years. Projections indicate it will reach $35.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.3%. This anticipated growth during the forecast period stems from factors such as heightened investments in precision medicine, the growing embrace of epigenetic therapeutics, the broader application of personalized oncology treatments, the expanding utilization of AI-driven genomic analysis, and increased partnerships between pharmaceutical companies and research institutions. Key trends anticipated for the same period encompass the wider application of epigenetic biomarkers in oncology, the increasing uptake of high-throughput epigenetic analysis tools, a rising need for DNA methylation assays, the expansion of drug discovery initiatives rooted in epigenetics, and improved integration of bioinformatics platforms.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Significant Factors Are Influencing The Epigenetics Market Expansion?

The epigenetics market is anticipated to expand due to a rising emphasis on precision medicine in the future. This medical strategy involves tailoring treatments to specific patient needs by analyzing their genetic makeup, environmental factors, and lifestyle details. Within epigenetics, precision medicine leverages individual epigenetic profiles and genetic information to develop customized healthcare plans, leading to improved disease management and patient treatment. An example of this trend is seen in data from March 2024, where Novotech, a biotechnology firm based in Australia, reported that in 2023, 43% of the 217 FDA-approved oncology therapies were precision oncology treatments, and 78 of these included DNA or NGS-detectable biomarkers. Consequently, the growing attention on precision medicine is fueling the expansion of the epigenetics market.

How Is The Epigenetics Market Organized By Segment Classification?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

What Trends Are Affecting The Direction Of The Epigenetics Market?

Major companies within the epigenetics market are increasingly focusing on incorporating artificial intelligence (AI)-driven analytics to achieve a competitive edge in the market. AI-driven analytics refers to the application of artificial intelligence (AI) technologies to automatically analyze and understand large volumes of data. For instance, in July 2023, FOXO Technologies, a US-based company, introduced Bioinformatics Services, designed to revolutionize epigenetic data analysis. FOXO’s Bioinformatics Services present a flexible platform of advanced data solutions specifically tailored to address the distinct needs of clients in academia, healthcare, and pharmaceutical research. Utilizing an innovative collection of bioinformatic tools, FOXO seeks to empower its clients to enhance the speed and accuracy of processing, analyzing, and interpreting data sets, thus accelerating discoveries and advancing their comprehension of complex diseases.

Who Are The Industry Participants Involved In The Epigenetics Market?

Major companies operating in the epigenetics market are Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Get The Full Epigenetics Market Report:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Where Is The Epigenetics Market Most Concentrated Geographically?

North America was the largest region in the epigenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Epigenetics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2026, By The Business Research Company

Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Epidural Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/epidural-catheter-global-market-report

Anesthesia Circuits And Regional Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-circuits-and-regional-anesthesia-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Epigenetics Market From 2026 To 2030?

The epigenetics market has witnessed rapid expansion recently. It is projected to increase from $12.74 billion in 2025 to $15.62 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.6%. This historical growth can be linked to factors such as a rise in cancer research, the broadening of academic genomics studies, the availability of sophisticated sequencing tools, an intensified focus on molecular diagnostics, and increased financial support for life sciences research.

The epigenetics market size is anticipated to undergo significant growth in the upcoming years. It is projected to expand to $35.01 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 22.3%. This expansion during the forecast period can be primarily ascribed to escalating investments in precision medicine, the increasing acceptance of epigenetic therapeutics, the broadening scope of personalized oncology treatments, the wider application of AI-driven genomic analysis, and strengthening collaborations between pharmaceutical entities and research institutions. Prominent developments for the forecast period include a heightened application of epigenetic biomarkers in oncology, a growing uptake of high-throughput epigenetic analysis tools, an increasing requirement for DNA methylation assays, the expansion of epigenetics-based drug discovery initiatives, and improved integration of bioinformatics platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Key Drivers Are Influencing The Growth Of The Epigenetics Market?

The epigenetics market is anticipated to expand due to a rising emphasis on precision medicine. This medical strategy involves tailoring treatments to individual patient needs by factoring in their genetic makeup, environmental influences, and lifestyle choices. Within epigenetics, precision medicine leverages unique epigenetic profiles and genetic information to develop customized healthcare plans, leading to more effective disease management and patient-specific treatments. An illustration of this trend is seen in data from March 2024 by Novotech, an Australia-based biotechnology firm, which reported that in 2023, 43% of the 217 oncology therapies approved by the FDA were precision oncology treatments, with 78 of these utilizing DNA or NGS-detectable biomarkers. Consequently, the heightened focus on precision medicine is fueling the expansion of the epigenetics market.

Which Segments Are Included In The Analysis Of The Epigenetics Market?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Which Trends Are Impacting The Growth Of The Epigenetics Market?

Leading companies within the epigenetics market are increasingly prioritizing the adoption of artificial intelligence (AI)-driven analytics to achieve a competitive advantage. AI-driven analytics refers to the application of artificial intelligence (AI) technologies to automatically process and interpret substantial data volumes. For example, in July 2023, FOXO Technologies, a US-based company, introduced Bioinformatics Services with the goal of revolutionizing epigenetic data analysis. FOXO’s Bioinformatics Services present a adaptable platform of advanced data solutions specifically designed to meet the unique demands of clients across academia, healthcare, and pharmaceutical research. By leveraging an innovative collection of bioinformatic tools, FOXO aims to enable its clients to enhance the speed and accuracy with which they manage, analyze, and interpret data sets, thereby accelerating discoveries and improving their understanding of complex diseases.

Which Key Industry Participants Are Active In The Epigenetics Market?

Major companies operating in the epigenetics market are Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Read the full epigenetics market report here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Epigenetics Market?

North America was the largest region in the epigenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Epigenetics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2026, By The Business Research Company

Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Epidural Catheter Market Report 2026

https://www.thebusinessresearchcompany.com/report/epidural-catheter-global-market-report

Anesthesia Circuits And Regional Anesthesia Disposables Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-circuits-and-regional-anesthesia-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Epigenetics Market from 2026 to 2030?

The epigenetics market has experienced substantial growth in recent years. It is anticipated to expand from $12.74 billion in 2025 to $15.62 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.6%. The historical expansion can be linked to factors such as increased cancer research endeavors, the broadening scope of academic genomics research, the provision of advanced sequencing instruments, an escalating focus on molecular diagnostics, and increased financial support for life sciences research.

The epigenetics market is projected for substantial expansion in the coming years. This market is anticipated to reach $35.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.3%. Several factors will drive this growth during the projected timeframe, including greater investments in precision medicine, the growing acceptance of epigenetic therapeutics, the broadening of personalized oncology treatments, the increasing application of AI-driven genomic analysis, and enhanced collaborations between pharmaceutical companies and research institutions. Key trends expected during the forecast period encompass the expanded application of epigenetic biomarkers in oncology, the increased uptake of high-throughput epigenetic analysis instruments, a rising demand for DNA methylation assays, the broadening of epigenetics-based drug discovery efforts, and improved integration of bioinformatics platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Drivers Are Affecting Demand In The Epigenetics Market?

The epigenetics market is expected to grow due to an increasing focus on precision medicine. Precision medicine is a medical strategy that considers an individual’s genetic, environmental, and lifestyle information to tailor treatment to their specific needs. In the context of epigenetics, this approach leverages individual epigenetic profiles and genetic data to develop personalized healthcare strategies, leading to more effective disease management and treatment for each patient. For example, in March 2024, Novotech, an Australia-based biotechnology company, reported that in 2023, 43% of the 217 FDA-approved oncology therapies were precision oncology treatments, with 78 of these incorporating DNA or NGS-detectable biomarkers. Therefore, the growing emphasis on precision medicine is a key driver for the expansion of the epigenetics market.

Which Segment Groups Are Influencing The Epigenetics Market?

The epigenetics market covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

What Trends Are Projected To Support The Growth Of The Epigenetics Market?

Key companies in the epigenetics market are intensifying their efforts to implement artificial intelligence (AI)-driven analytics, seeking to gain a competitive advantage. AI-driven analytics refers to the application of artificial intelligence (AI) technologies to automatically analyze and interpret vast amounts of data. For example, in July 2023, FOXO Technologies, a US-based firm, unveiled Bioinformatics Services designed to revolutionize epigenetic data analysis. FOXO’s Bioinformatics Services present a adaptable platform of advanced data solutions, tailored to address the particular demands of clients involved in academia, healthcare, and pharmaceutical research. Utilizing an innovative array of bioinformatic tools, FOXO intends to enable its clients to improve the speed and accuracy of data set processing, analysis, and interpretation, thereby accelerating discoveries and enhancing their comprehension of complex diseases.

Who Are The Major Companies Operating In The Epigenetics Market?

Major companies operating in the epigenetics market are Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Epigenetics Market?

North America was the largest region in the epigenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Epigenetics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2026, By The Business Research Company

Anesthesia Disposables Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Epidural Catheter Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/epidural-catheter-global-market-report

Anesthesia Circuits And Regional Anesthesia Disposables Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/anesthesia-circuits-and-regional-anesthesia-disposables-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the epigenetics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Epigenetics Market Size?

The epigenetics market has experienced rapid expansion in recent years. Its size is expected to grow from $10.65 billion in 2024 to $12.74 billion in 2025, achieving a compound annual growth rate (CAGR) of 19.6%. The historical growth of this market is attributable to increased research funding, a rise in the incidence of chronic diseases, advancements in personalized medicine, significant progress in cancer research, and the presence of an aging population.

The epigenetics market is poised for significant expansion over the next few years. It is projected to reach $28.68 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 22.5%. This growth during the forecast period is fueled by epigenetic drug development, the role of epigenetics in environmental health, its application in precision agriculture, robust regulatory support, and increasing patient awareness and advocacy. Notable trends expected in this period include epitranscriptomics, single-cell epigenomics, epigenetic editing, the discovery of epigenetic biomarkers, advances in aging and longevity research, and studies on microbiome-epigenome interactions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Core Market Drivers Are Expanding The Epigenetics Industry?

An escalating incidence of cancer and various other diseases is a significant factor propelling the growth of the epigenetics market. This rising prevalence of diseases consequently increases the demand for epigenetics. For example, in May 2024, information from the National Cancer Institute (NCI), a US-based Government agency, indicated that in 2022, nearly 20 million new cancer cases were reported, resulting in approximately 9.7 million deaths attributed to the disease. Projections further suggest that by 2040, the annual occurrence of new cancer cases will rise to 29.9 million, with cancer-related deaths reaching 15.3 million. Moreover, according to the Centers for Disease Control and Prevention (CDC), an estimated 659,000 people in the United States die of heart disease annually. The increasing prevalence of cancer and other diseases necessitates thorough testing and understanding of genetic modifications, which will invariably boost the utilization and demand for epigenetics. Thus, the growing prevalence of cancer and other diseases is poised to drive the epigenetics market in the coming years.

What Segment Insights Are Highlighted In The Epigenetics Market Report?

The epigeneticsmarket covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Which Notable Trends Are Transforming The Epigenetics Market Outlook?

Key companies active in the epigenetics market are prioritizing the development of technologically advanced solutions, such as DNA sequencing methods, with the aim of improving precision medicine and enhancing disease understanding and treatment outcomes. DNA sequencing methods are processes utilized to ascertain the order of nucleotides within a DNA molecule, thereby enabling thorough genetic analysis. This information is indispensable for detecting genetic variations linked to diseases and advancing precision medicine. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, unveiled its Illumina Complete Long Read Technology. This technology supports both long-read and short-read sequencing on a single instrument, considerably increasing versatility in genomic research. By requiring less DNA input and featuring a streamlined workflow, it simplifies the library preparation process, making it suitable even for challenging samples. The technology also achieves high accuracy in variant calling, supplying dependable data crucial for comprehensive genomic analysis.

Which Firms Are Driving Innovation Within The Epigenetics Market?

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

What Regional Trends Are Shaping Growth In The Epigenetics Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Tumor Embolization Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Global Market Value Of The Epigenetics Industry In 2025?#_x000D_

The overall valuation of the epigenetics market has witnessed substantial expansion lately, projected to ascend from its 2024 figure of $10.65 billion to reach $12.74 billion by 2025, reflecting a compound annual growth rate (CAGR) of 19.6%; this vigorous expansion seen during the past period stemmed from various factors including augmented financial backing for research endeavors, a growing prevalence of long-term illnesses, the advancement of tailored medical treatments, intensifying efforts in cancer studies, and the demographic shift towards an older populace._x000D_

_x000D_

The overall valuation of the epigenetics sector is projected to undergo substantial escalation over the forthcoming years, culminating in a market size of $28.68 billion by 2029, driven by a compound annual growth rate (CAGR) of 22.5%. This anticipated expansion throughout the projection timeframe is fundamentally linked to several key factors, such as advancements in epigenetic therapeutic agent creation, the application of epigenetics within ecological wellbeing studies, its integration into targeted crop management, favorable governmental policies, and increased cognizance and support activities among the public. During this forecast interval, the primary industry trajectories involve developments in epitranscriptomics, the study of epigenomics at the resolution of a single cell, mechanisms for epigenetic modification, identifying epigenetic indicators, investigations into senescence and lifespan extension, and the reciprocal relationship between the microbiome and the epigenome._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp_x000D_

_x000D_

#What Are The Key Drivers Of Growth In The Epigenetics Market?#_x000D_

The notable increase in instances of cancer alongside other illnesses is a major catalyst for the expansion observed within the epigenetics sector; this surge in disease frequency directly fuels the need for epigenetics solutions. To illustrate this point, data released in May 2024 by the National Cancer Institute, a governmental body in the U.S., showed that roughly 20 million new cancer diagnoses were made globally in 2022, contributing to an estimated 9.7 million fatalities attributed to the ailment, with forecasts suggesting that by 2040, the yearly count of new cancer cases will climb to 29.9 million, alongside 15.3 million cancer-related deaths. Moreover, statistics from the Centers for Disease Control and Prevention (CDC) reveal an annual toll of approximately 659,000 cardiovascular disease deaths within the United States. Consequently, the escalating rates of cancer and similar conditions necessitate advanced diagnostic capabilities to identify underlying genetic alterations, which consequently boosts the adoption and requirement for epigenetic technologies, thus positioning the rising incidence of these ailments as a key driver for the epigenetics market in the foreseeable future._x000D_

_x000D_

#What Are The Different Segment Classifications Within The Epigenetics Market?#_x000D_

The epigeneticsmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product: Reagents, Enzymes, Instruments, Kits _x000D_

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures _x000D_

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications _x000D_

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes_x000D_

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes_x000D_

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers_x000D_

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits_x000D_

_x000D_

#Which Competitive Trends Are Defining The Epigenetics Market Structure?#_x000D_

Leading enterprises within the epigenetics sector are concentrating efforts toward creating sophisticated technological instruments, exemplified by advancements in DNA sequencing methodologies, with the ultimate goal of elevating the effectiveness of personalized healthcare and deepening comprehension of ailments along with their therapeutic results. Determining the precise sequence of nucleobases within a deoxyribonucleic acid structure constitutes DNA sequencing—a process vital for in-depth genetic scrutiny. This resulting data proves indispensable for pinpointing genetic alterations linked to various conditions and propelling the field of precision medicine forward. To illustrate, during March of 2023, the American biotech firm Illumina Inc. introduced its Complete Long Read Technology, a dual-capability system allowing both extended and brief sequencing reads from one piece of equipment, thereby markedly boosting adaptability in genomic studies, while simultaneously demanding less initial DNA material and featuring a simplified procedure that eases the burden of preparing samples, even those that present difficulties, ultimately delivering superior accuracy in identifying variations which furnishes dependable information necessary for exhaustive genomic evaluation._x000D_

_x000D_

#Which Major Industry Participants Are Leading The Epigenetics Market Growth?#_x000D_

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report_x000D_

_x000D_

#Which Region Is Projected To Lead The Epigenetics Market During The Forecast Period?#_x000D_

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Request A Customized Version Of The Epigenetics Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Epigenetics Market 2025, By The Business Research Company#_x000D_

_x000D_

Viral Vectors And Plasmid Dna Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report_x000D_

_x000D_

Cancer Tumor Profiling Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report_x000D_

_x000D_

Tumor Embolization Devices Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Epigenetics Market Expected to Grow Between 2025 And 2029?

In recent times, we’ve seen a swift growth of the epigenetics market size. The prediction shows a development from $10.65 billion in 2024 to $12.74 billion in 2025, with a compound annual growth rate (CAGR) of 19.6%. Factors contributing to the growth during the historic period include an increase in research funding, growing occurrence of chronic diseases, advancement in personalized medicine, cancer research, and an aging population.

There’s an anticipated significant surge in the epigenetics market in the coming years, with the market size projected to reach $28.68 billion by 2029, growing at a compound annual growth rate (CAGR) of 22.5%. The predicted expansion during this period is linked to factors such as the development of epigenetic drugs, the role of epigenetics in environmental health and precision agriculture, favourable regulatory frameworks, and increased patient awareness and advocacy. Additionally, the period is expected to witness certain trends such as epitranscriptomics, single-cell epigenomics, epigenetic editing, the identification of epigenetic biomarkers, research in aging and longevity, and the interaction between microbiomes and epigenomes.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Which Factors and External Forces Are Driving Demand in the Epigenetics Market?

The escalating occurrence of cancer and other illnesses is substantially fuelling the expansion of the epigenetics market. The growing incidence of these diseases heightens the need for epigenetics. For instance, in May 2024, the National Cancer Institute (NCI), a US-based government organization, reported that nearly 20 million new cases of cancer were reported in 2022, leading to approximately 9.7 million deaths from the disease. Estimates suggest that by 2040, the annual rate of new cancer diagnoses will rise to 29.9 million, while cancer-related deaths will hit 15.3 million. Additionally, according to the Centers for Disease Control and Prevention (CDC), around 659,000 individuals in the United States succumb to heart disease annually. The escalating occurrence of cancer and other conditions necessitates the testing and understanding of genetic modifications, which will inevitably boost the utilization and demand for epigenetics. Therefore, the escalating occurrence of cancer and other illnesses is set to propel the epigenetics market in the upcoming years.

Which Segments in the Epigenetics Offer the Most Growth?

The epigeneticsmarket covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Epigenetics Market?# Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theEpigenetics Market’s Growth?

Significant entities within the epigenetics market are channeling their efforts to create cutting-edge solutions such as DNA sequencing methodologies. These methods aim to augment precision medicine, enrich disease comprehension, and better therapeutic results. DNA sequencing techniques are instrumental in identifying the sequence of nucleotides within a DNA molecule, a crucial aspect of in-depth genetic analysis. The insights derived from this process play a critical role in locating genetic variations linked to diseases, thus propelling the advancement of precision medicine. For example, Illumina Inc., a biotech company based in the U.S., rolled out the Illumina Complete Long Read Technology in March 2023. This technology harmonizes the process of long-read and short-read sequencing within a single instrument, greatly boosting versatility in the field of genomics studies. The technology reduces DNA input demands and optimizes the workflow, thus simplifying the preparation of libraries, even for the more intricate samples. The system’s efficacy at accurately calling variants ensures the delivery of trustworthy data vital for thorough genomic analysis.

View the full report here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

What Are the Key Elements That Define the Epigenetics Market?

Epigenetics is a change in gene activity transmitted to younger cells without modifying the DNA sequence. Epigenetic processes are natural and necessary for many organisms to work, but unusual occurrences can cause disorders, such as various types of cancer, reproductive illnesses, and cardiovascular illnesses. Epigenetics is used detect a type of cancers earlier.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model